Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
LifeQuest World Corporation (LQWC)
Ridgefield Park, NJ, US
LifeQuest World Corporation, operating through its subsidiary entities, specializes in delivering comprehensive solutions for managing and treating both sewage and industrial effluents. The company engineers onsite wastewater treatment systems capable of purifying grey and black water, rendering it fit for reuse in applications like irrigation, toilet flushing, and cleaning. Furthermore, LifeQuest tackles the purification of industrial wastewater across diverse sectors such as textile, tannery, fisheries, dairy, and processed water industries. Among its key offerings is Biopipe, an advanced biological wastewater treatment system deployed in a broad range of settings, including private residences, commercial and multi-unit developments, hotels, hospitals, industrial complexes, and recreational areas. It also provides Abrimix, a water treatment technology versatile enough to process wastewater, processed water, and raw water sources. For water filtration needs, LifeQuest supplies Glanris, a non-toxic filtration media utilized by municipalities, businesses, and individual homeowners and consumers alike. The company also features Goslyn, a grease recovery device specifically engineered to efficiently remove fats, oils, and grease (FOG) from wastewater effluents. Founded in 1997, LifeQuest World Corporation maintains its headquarters in Ridgefield Park, New Jersey.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | -6.54% | -29.78% | -26.66% | -25.87% | +2.56% | -60.00% | -94.37% | -95.83% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Industrial - Pollution & Treatment Controls: +8.0%-36.9% Q1'26: +42.6% (vs Q4'24)
-
EPS growth Industrial - Pollution & Treatment Controls: +15.8%-121.4% Q1'26: +100.0% (vs Q4'24)
-
FCF margin FCF growth · Industrial - Pollution & Treatment Controls: +35.7%+89.8% Q1'26: -131.6% (vs Q4'24)
-
EBIT margin Industrial - Pollution & Treatment Controls: +10.2%-238.9% Q1'26: -2.2% (vs Q4'24)
-
ROIC Industrial - Pollution & Treatment Controls: +6.6%— Q1'26: +38.7% (vs Q4'24)
-
Share dilution Industrial - Pollution & Treatment Controls: 0.0%+0.4% Q1'26: +3.1% (vs Q4'24)
-
Debt / EBITDA Net debt/EBITDA · Industrial - Pollution & Treatment Controls: -0.39×-0.10× Q1'26: 0.31× (vs Q4'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2008-11-25 | JURAK ANTHONY CARL | Director / Officer / 10% Owner | A-Award | A | Preferred Stock, Seires B | 10,000,000 | 0.00 | — | 10,000,000 | — | ↗ |
| 2007-07-17 | JURAK ANTHONY CARL | Director / Officer | G-Gift | D | Common Stock | 18,788,675 | 0.75 | 14.09M | 49,694,210 | — | ↗ |
| 2006-06-02 | JURAK ANTHONY CARL | Director / Officer | G-Gift | D | Common | 1,986,596 | 0.00 | — | 87,991,122 | — | ↗ |
| 2006-05-29 | Theriault Roger | Director / Officer | A-Award | A | Common | 6,504,360 | 0.02 | 130.1K | 8,004,360 | — | ↗ |
| 2006-05-29 | JURAK ANTHONY CARL | Director / Officer / 10% Owner | A-Award | A | Common | 18,788,675 | 0.02 | 375.8K | 42,208,175 | — | ↗ |
| 2006-02-26 | JURAK ANTHONY CARL | Director / Officer / 10% Owner | A-Award | A | Common Stock | 11,500,000 | 0.10 | 1.15M | 23,419,500 | — | ↗ |
| 2005-09-23 | JURAK ANTHONY CARL | Director / Officer / 10% Owner | G-Gift | D | Common Stock | 50,000 | 0.00 | 50.00 | 11,919,500 | — | ↗ |
| 2005-05-31 | Theriault Roger | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2005-05-31 | JURAK ANTHONY CARL | Director / Officer / 10% Owner | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2005-05-31 | Guedes Maria Jose | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2005-04-30 | Theriault Roger | Director | G-Gift | D | COMMON STOCK | 300,000 | 0.00 | — | 2,700,000 | — | ↗ |
| 2005-01-10 | Guedes Maria Jose | Officer | P-Purchase | A | COMMON STOCK | 453,384 | 0.20 | 90.7K | 453,384 | — | ↗ |
| 2004-05-31 | Theriault Roger | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2004-05-31 | Guedes Maria Jose | Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2003-11-05 | JURAK ANTHONY CARL | Director / Officer / 10% Owner | G-Gift | D | Common Stock | 1,000,000 | 0.00 | — | 12,039,000 | — | ↗ |
| 2003-10-31 | Theriault Roger | Director / Officer | J-Other | A | COMMON STOCK | 1,500,000 | 0.00 | — | 3,000,000 | — | ↗ |
| 2003-05-31 | Theriault Roger | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 1,500,000 | — | ↗ |
| 2003-05-31 | Guedes Maria Jose | Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2002-05-31 | Theriault Roger | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 1,500,000 | — | ↗ |
| 2002-05-31 | Guedes Maria Jose | Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2002-05-12 | JURAK ANTHONY CARL | Director / Officer / 10% Owner | P-Purchase | A | COMMON STOCK | 919,500 | 0.27 | 248.3K | 9,220,000 | — | ↗ |
| 2001-05-31 | Theriault Roger | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 1,500,000 | — | ↗ |
| 2001-05-31 | Guedes Maria Jose | Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2001-03-27 | Guedes Maria Jose | Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2000-05-31 | Theriault Roger | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 1,500,000 | — | ↗ |
| 1999-05-31 | Theriault Roger | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 1,500,000 | — | ↗ |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Freddie Canta | SVP of Biopipe Global & Country Head of Philippines | — | male |
| Max Khan | President, Chief Executive Officer, Secretary, Treasurer & Director | — | male |
| Mehmet Enes Kutluca | Founder, COO, CTO & Director | — | male |
| Nina Aquino | CMO of Biopipe Global | — | female |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for LQWC
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
